Notably, TTK protein expression in neoadjuvant chemotherapy‐treated breast cancer patients was up‐regulated post‐therapy and correlated with reduced survival, highlighting TTK as a breast cancer biomarker and possible therapeutic target. The gene discussed is TTK; the disease is breast carcinoma.